(Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | (FY)Jul 31, 2022 | (Q4)Jul 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 49.59%-110.68K | -18.82%-278.36K | -54.31%-305.73K | 28.07%-779.8K | 80.83%-127.64K | 12.11%-219.57K | -878.53%-234.26K | -34.74%-198.13K | -6.93%-1.08M | -230.73%-665.72K |
Net income from continuing operations | 78.63%-58.38K | -202.11%-492.8K | 45.46%-131.5K | 63.42%-993.04K | 52.91%-315.59K | 31.46%-273.23K | 50.94%-163.12K | 81.68%-241.1K | 52.25%-2.71M | 85.21%-670.22K |
Operating gains losses | -967.17%-53.51K | 2,738.96%72.33K | -882.70%-52.76K | -55.53%60.12K | -53.09%62.21K | 2,654.91%6.17K | -172.11%-2.74K | 568.78%6.74K | 158.87%135.2K | 54.24%132.62K |
Depreciation and amortization | -102.97%-682 | --0 | -95.62%682 | -18.15%25.95K | -294.03%-31.57K | 347.83%22.94K | 269.94%19.21K | 204.24%15.58K | 45.99%31.71K | 225.96%16.27K |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | --0 | --0 | ---- | -70.57%1.18M | -97.35%106.59K |
Remuneration paid in stock | ---- | ---- | ---- | 263.99%130.16K | ---- | --0 | --0 | ---- | -90.31%35.76K | --0 |
Other non cashItems | --17.92K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -44.79%89.15K | -81.08%5.45K |
Change In working capital | -165.26%-16.02K | 231.51%115.22K | -691.36%-122.15K | -101.94%-3K | 118.43%47.26K | -75.53%24.55K | -134.81%-87.61K | -64.94%20.66K | 262.52%154.51K | -30,573.56%-256.43K |
-Change in receivables | -229.87%-191.64K | -125.19%-20.35K | 58.20%-18.23K | 123.59%15.27K | 141.81%37.63K | -18.52%-58.1K | 1.42%80.78K | -709.22%-43.61K | -2,515.39%-64.76K | -1,401.45%-90K |
-Change in prepaid assets | 237.84%14.91K | -703.53%-18.14K | -108.20%-4.67K | 205.08%58.76K | 119.36%9.56K | 26.01%-10.82K | -65.44%3.01K | 9,281.48%57.02K | -1,913.83%-55.92K | -804.81%-49.38K |
-Change in payables and accrued expense | 71.94%160.71K | 189.68%153.7K | -1,469.32%-99.25K | -127.99%-77.03K | 100.06%75 | -43.00%93.47K | -204.94%-171.39K | -88.84%7.25K | 474.83%275.19K | -693.23%-117.06K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 49.59%-110.68K | -18.82%-278.36K | -54.31%-305.73K | 28.07%-779.8K | 80.80%-127.84K | 12.11%-219.57K | -878.53%-234.26K | -436.27%-198.13K | -6.93%-1.08M | -230.73%-665.72K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 120.74%22.33K | -3,752.16%-4.22M | 69.61%-37.29K | 92.16%-76.81K | 138.75%145.33K | 105.94%10.12K | 56.41%-109.58K | -27.06%-122.68K | -115.60%-979.81K | -81.82%-375.09K |
Net PPE purchase and sale | --0 | --0 | --0 | 129.15%53.11K | 99.37%-980 | 1,487.46%92.79K | -298.97%-26.84K | 0.91%-11.87K | -392.34%-182.17K | -3,063.96%-156.77K |
Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net business purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---99.41K | ---- | ---- |
Net investment purchase and sale | --0 | ---- | ---- | 50.30%-99.41K | --0 | ---- | ---- | ---- | ---200K | ---- |
Net other investing changes | 127.01%22.33K | 306.63%170.96K | -226.92%-37.29K | 94.90%-30.51K | 223.66%146.31K | 49.48%-82.68K | 42.79%-82.74K | 86.51%-11.41K | -43.16%-597.65K | 41.23%-118.32K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 120.74%22.33K | -3,752.16%-4.22M | 69.61%-37.29K | 92.16%-76.81K | 138.75%145.33K | 105.94%10.12K | 56.41%-109.58K | -27.06%-122.68K | -115.60%-979.81K | -81.82%-375.09K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -199.27%-105.88K | 109,931.82%4.95M | 4.34%182.59K | -86.48%311.48K | -96.90%25.33K | -83.68%106.65K | -99.40%4.5K | 175K | 645.07%2.3M | 163.34%816.89K |
Net issuance payments of debt | -307.60%-105.88K | 109,931.82%4.95M | -109.95%-17.41K | -83.30%260.5K | -113.44%-26.9K | -92.27%51K | -99.36%4.5K | --175K | 680.04%1.56M | 0.04%200.08K |
Net common stock issuance | --0 | --0 | --200K | -101.11%-5.92K | -101.15%-4.68K | 81.11%-1.25K | --0 | --0 | 387.30%531.75K | 267.93%405.46K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | -73.08%56.9K | ---- | --56.9K | ---- | ---- | --211.36K | --211.36K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -199.27%-105.88K | 109,931.82%4.95M | 4.34%182.59K | -86.48%311.48K | -96.90%25.33K | -83.68%106.65K | -99.40%4.5K | --175K | 645.07%2.3M | 163.34%816.89K |
Net cash flow | ||||||||||
Beginning cash position | 113.20%375.03K | -76.20%124.24K | -90.65%56.72K | 52.29%606.46K | -80.78%147.67K | -69.11%175.91K | 259.48%522.04K | 52.29%606.46K | -74.90%398.22K | 58.69%768.28K |
Current changes in cash | -88.93%-194.22K | 233.21%452.03K | -10.02%-160.43K | -327.80%-545.13K | 119.12%42.82K | -144.08%-102.8K | -171.11%-339.34K | 40.14%-145.81K | 120.65%239.31K | -129.94%-223.93K |
Effect of exchange rate changes | 30.98%97.66K | -2,859.14%-201.25K | 271.29%227.95K | 85.18%-4.6K | -315.37%-133.76K | 317.17%74.56K | 87.18%-6.8K | 752.98%61.39K | -7.20%-31.07K | 440.86%62.11K |
End cash Position | 88.58%278.47K | 113.20%375.03K | -76.20%124.24K | -90.65%56.72K | -90.65%56.72K | -80.78%147.67K | -69.11%175.91K | 259.48%522.04K | 52.29%606.46K | 52.29%606.46K |
Free cash from | 51.19%-110.68K | -6.61%-278.36K | -45.59%-305.73K | 34.24%-832.68K | 81.34%-134.82K | 11.60%-226.76K | -99.82%-261.1K | -547.36%-210K | -20.50%-1.27M | -250.31%-722.5K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data